|
Flores MA, Fortea P, Trinidad EM, García D, Soler G, Ortuño FJ, Zapata AG, Alonso-Colmenar LM. EphrinA4 plays a critical role in ?4 and ?L mediated survival of human CLL cells during extravasation. Oncotarget. 2016 Jul 26;7(30):48481-48500. doi: 10.18632/oncotarget.10311. PubMed PMID: 27374180; PubMed Central PMCID: PMC5217033.
AÑO: 2016; IF: 5.168
|
27374180
|
Blanco G, Puiggros A, Baliakas P, Athanasiadou A, García-Malo M, Collado R, Xochelli A, Rodríguez-Rivera M, Ortega M, Calasanz MJ, Luño E, Vargas M, Grau J, Martínez-Laperche C, Valiente A, Cervera J, Anagnostopoulos A, Gimeno E, Abella E, Stalika E, Hernández-Rivas JM, Ortuño FJ, Robles D, Ferrer A, Ivars D, González M, Bosch F, Abrisqueta P, Stamatopoulos K, Espinet B. Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations. Oncotarget. 2016 Dec 6;7(49):80916-80924. doi: 10.18632/oncotarget.13106. PubMed PMID: 27821812; PubMed Central PMCID: PMC5348364.
AÑO: 2016; IF: 5.168
|
|
Hurtado AM, Chen-Liang TH, Przychodzen B, Hamedi C, Muñoz-Ballester J, Dienes B, García-Malo MD, Antón AI, de Arriba F, Teruel-Montoya R, Ortuño FJ, Vicente V, Maciejewski JP, Jerez A. Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia. Blood Cancer J. 2015 Aug 28;5:e342. doi: 10.1038/bcj.2015.65. PubMed PMID: 26314984; PubMed Central PMCID: PMC4558590.
AÑO: 2015; IF: 4.411
|
|
Ortuño FJ, Sola M. Extreme dyserythropoiesis in the setting of acute erythroid leukemia. Blood. 2015 Sep 10;126(11):1391. PubMed PMID: 26605391.
AÑO: 2015; IF: 11.847
|
|
Chen-Liang TH, Jerez A, Ortuño FJ. Reply to Adams and Kwee. Am J Hematol. 2015 Sep;90(9):E183. doi: 10.1002/ajh.24071. PubMed PMID: 26014272.
AÑO: 2015; IF: 5.0
|